logo
  

Nokia Unveils Asia's First TDD-FDD 3 Carrier Aggregation With Commercial Chipset

Nokia Networks (NOK) Wednesday said it has demonstrated Asia's first TDD-FDD 3 carrier aggregation using the Snapdragon X12 LTE modem.

The Snapdragon X12 LTE modem is a product of Qualcomm Technologies, Inc., a subsidiary of Qualcomm Incorporated.

According to Nokia, peak downlink speeds of 365 Mbps were achieved, with 20 MHz of FDD band 1 and 40 MHz of TDD band 41 contributing to 145 Mbps and 220 Mbps, respectively.

Radio equipment from Nokia's Specialized Technology Center in Japan supported this lab test with Qualcomm Technologies.

Nokia Networks solutions that enabled the demonstration include Commercial Single RAN Advanced hardware, including the Flexi Multiradio 10 Base Station for LTE and TD-LTE, as well as load balancing capabilities to facilitate optimal utilization of spectrum resources for delivering an unmatched LTE service experience.

Software to aggregate carriers on TDD and FDD LTE spectrums also helped enable the demonstration.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT